This is evident from the divergent prognostic implications in these two cellular compartments in non-small cell lung cancer (NSCLC): High Gal-9 expression on the tumor cells is correlated with improved OS in NSCLC patients [35]. The gene discussed is LGALS9; the disease is neoplasm.